G. Chetrite et al., EFFECT OF PROMEGESTONE, TAMOXIFEN, 4-HYDROXYTAMOXIFEN AND ICI 164,384ON THE ESTRONE SULFATASE ACTIVITY OF HUMAN BREAST-CANCER CELLS, Anticancer research, 13(4), 1993, pp. 931-934
In the present study, we explored the effects on sulphatase activity b
y Promegestone (R-5020), Tamoxifen (TAM), 4-hydroxytamoxifen (4-OH-TAM
) and ICI 164,384 in the T-47D hormone-dependent and MDA-MB-231 hormon
e-independent mammary cancer cell lines. Using homogenates of these ce
lls it was observed that Promegestone has a significant effect on the
inhibition of oestrone (E1) sulphatase activity. As this effect is com
petitive, it is suggested that there is a direct action of this compou
nd on the enzyme. Tamoxifen has very little or no effect, 4-hydroxytam
oxifen has an intermediate effect and ICI 164,384 is active in the enz
yme inhibition, particularly with MDA-MB-231 cells. The present data c
ould open new possibilities for human breast cancer treatment, as sulp
hatase is very active in the first step of the conversion of oestrone
sulphate (E1S) to oestradiol (E2), and oestradiol is one of the princi
pal carcinogenic factors in human hormone-dependent breast cancer.